Articles On Amplia Therapeutics (ASX:ATX)

What's happened? Amplia Therapeutics Limited (ATX:ASX, "Amplia") have made a key addition to their Scientific Advisory Board. What are the key highlights? Professor Paul Timpson has been appointed to Amplia's Scientific Advisory Board. Prof...

Our summary of Amplia Therapeutics Ltd's recent announcement What's happened? Amplia Therapeutics Limtied (ASX:ATX) have undertaken a capital raising. What are the key highlights? $0.93 million raised. Platinum International Healthcare Fun...

The health sector was the most successful sector on the ASX in 2019. Various small caps made several breakthroughs including with nerve damage and macular degeneration. While cancer remains one fish that has yet to be fried there are small...

In 2019 the culmination of decades worth of work turned several biotechs and life sciences companies into overnight successes. As investors look to defensive growth stocks to compensate for a sluggish economy and with expectations of more h...

Headlines are being made in the US today with a Republican Congressman expected to plead guilty to insider trading charges brought by the US securities regulator the SEC. Making the case unusual is that the micro-cap biotech in question is...

Whatever you think of Audio Pixels (ASX:AKP) you cannot deny it’s been a spectacular investment for those who got in early. From 15c 10 years ago to $18.45 on Friday, it has gained over 12,000 per cent. It is the second greatest 10-year gai...

In the three months since Stockhead last looked at the performance of equity capital market firms – the market has seen several more deals and a couple of acquisitions. In June, Shaw and Partners revealed it was acquiring DJ Carmichael and...

Coming after trial flops from Factor Therapeutics (ASX:FTT), Innate Immunotherapeutics (now Amplia Therapeutics, ASX:ATX) and Bionomics (ASX:BNO), investors were awaiting the phase IIb results from the eye diseases house with more than a de...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

In this article, we would discuss three healthcare stocks from ASX. On 23 July 2019, these companies have released significant updates pertaining to their respective business. The Australian benchmark index was trading at 6,780.6, up by 55....

Amplia Therapeutics (ASX: AMP) shares surged this morning after announcing positive pre-clinical data for its anti-cancer drug. The drug, AMP945, targets Focal Adhesion Kinase (FAK). It’s a protein in humans that help cancer cells spread. (...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...